Revolution Medicines, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 5 Aug 2026Quarterly earnings show if the company is making progress and spending money wisely.
Quarterly earnings show if the company is making progress and spending money wisely.
Leadership changes affect company direction and investor confidence in management.
Quarterly earnings show if the company is making progress and spending money wisely.
Quarterly earnings show if the company is making progress and spending money wisely.
Raising money through debt helps fund operations but creates obligation to repay later.
Selling new stock raises money but dilutes ownership stake of current shareholders.
Stocky reads Revolution Medicines, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Revolution Medicines, Inc.'s most recent tracked filing was a 10-Q on 5 Aug 2026: Reported Q2 2026 financial results on August 5.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 5 Aug 2026.